Cite
HARVARD Citation
Huang, D. et al. (2019). The incidence and patient outcomes of ABSSSI by iclaprim MIC values in the phase 3 REVIVE trials for treatment of acute bacterial skin and skin structure infections. Journal of medical microbiology. 68 (6), p. . [Online].